comparemela.com

Page 2 - Shorla Oncology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TechIreland survey shows start-up funding dropped by more than a third in 2023

TechIreland survey shows start-up funding dropped by more than a third in 2023
techcentral.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from techcentral.ie Daily Mail and Mail on Sunday newspapers.

John odeaBrian caulfieldBelfast weevTechireland john odeaJohno deaCork based everseenShorla oncologyVivasure medicalEnterprise irelandScale ireland

Novotech Publishes Research Report on Acute Myeloid Leukaemia Clinical Trial Landscape for Clinical Stage Biotechs

Novotech Publishes Research Report on Acute Myeloid Leukaemia Clinical Trial Landscape for Clinical Stage Biotechs
koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.

United statesDavid jamesCytosinlab therapeutics coOncoverity incContract research organizationCystic fibrosisGlobal clinical trial landscapeKorea bizwireAcute myeloid leukaemiaAcute myeloid leukemiaNorth americaMainland chinaOpna bioShorla oncologyCytosinlab therapeuticsAntibody drug conjugates

Shorla Oncology Announces FDA Filing Acceptance of New Drug Application to Treat Certain Forms of Leukemia and Other Cancers

CAMBRIDGE, Mass., April 08, 2024 Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) for SH-201, the first palatable oral liquid of the related chemotherapeutic agent to treat certain forms of leukemia and other cancers. The Agency assigned a Prescription Drug User Fee Act ("PDUFA") action date of November 30, 2024.

United statesUnited kingdomSharon cunninghamOrlaith ryanDrug administrationDawn communicationsAmerican cancer societyUs ireland pharmaceutical companyShorla oncology announcedOral liquid drugIreland pharmaceuticalCertain typesShorla oncologyNew drug applicationPrescription drug user fee actChief executive officer

FDA Accepts NDA for SH-201 in Leukemia and Other Cancers

The FDA has accepted for review the new drug application for SH-201 for the treatment of patients with certain forms of leukemia and other cancers.

United statesSharon cunninghamOrlaith ryanPrescription drug user fee actShorla oncology

Ireland is a leading light in Europe for venture capital input into startups led by women

Ireland is a European leader when it comes to venture capital (VC) investment in female-led startups, according to a new report from financial data and research firm PitchBook.

Orlaith ryanAnna marie turleySarah jane larkinHelen mcbreenDebbie rennickDavid bowlesJennifer carroll macneillIrish venture capital associationLab europeFemale foundersEnterprise irelandAtlantic bridgeYield lab europeCaroline sherryShorla oncologyKaren may

vimarsana © 2020. All Rights Reserved.